ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,277.51
      0.80%
      US Tech 100
      18,064.80
      0.02%
      Dow Jones
      38,686.32
      1.51%
      Brent Oil
      81.295
      0.00%
      Bitcoin
      67,515.34
      -0.31%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Evaxion Biotech AS (EVAX)

      7. Evaxion Biotech AS (EVAX) News

      EVAX

      Evaxion Biotech AS (EVAX)

      Evaxion Biotech AS
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:EVAX
      DateTimeSourceHeadlineSymbolCompany
      05/28/20249:30AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
      05/28/20248:21AMGlobeNewswire Inc.Evaxion Announces Business Update and First Quarter 2024 Financial ResultsNASDAQ:EVAXEvaxion Biotech AS
      05/24/20244:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
      05/23/20245:05PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
      05/23/20245:00PMGlobeNewswire Inc.Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at the American Society of Clinical Oncology Annual Meeting 2024NASDAQ:EVAXEvaxion Biotech AS
      05/10/20245:29PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
      05/10/20245:00PMGlobeNewswire Inc.Evaxion Receives Nasdaq NotificationNASDAQ:EVAXEvaxion Biotech AS
      05/06/20245:01PMEdgar (US Regulatory)Form F-1 - Registration statement for certain foreign private issuersNASDAQ:EVAXEvaxion Biotech AS
      04/17/20248:00AMGlobeNewswire Inc.Evaxion Announces Phase 2 Clinical Trial Update: First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01NASDAQ:EVAXEvaxion Biotech AS
      04/02/20247:00AMGlobeNewswire Inc.Evaxion and Undisclosed Collaborator Announce Encouraging Results for EVX-B1 Vaccine Antigens Against Staphylococcus Aureus InfectionNASDAQ:EVAXEvaxion Biotech AS
      03/27/20247:30AMGlobeNewswire Inc.Evaxion Announces Business Update and Full Year 2023 Financial ResultsNASDAQ:EVAXEvaxion Biotech AS
      03/19/20247:30AMGlobeNewswire Inc.Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™ PlatformNASDAQ:EVAXEvaxion Biotech AS
      02/29/20247:35AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
      02/29/20247:30AMGlobeNewswire Inc.Evaxion to Host R&D Day on March 19, 2024, Highlighting its Latest Technology InnovationsNASDAQ:EVAXEvaxion Biotech AS
      02/20/20247:32AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
      02/20/20247:30AMGlobeNewswire Inc.Evaxion Announces Successful Completion of the Initial Phases of Ongoing Vaccine Collaboration with MSDNASDAQ:EVAXEvaxion Biotech AS
      02/07/20244:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
      02/07/20248:30AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
      02/07/20248:30AMGlobeNewswire Inc.Evaxion Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:EVAXEvaxion Biotech AS
      02/06/20248:30AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
      02/06/20248:30AMGlobeNewswire Inc.Evaxion Announces Closing of $15 Million Public OfferingNASDAQ:EVAXEvaxion Biotech AS
      02/05/20249:09AMEdgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:EVAXEvaxion Biotech AS
      02/05/20247:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
      02/02/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:EVAXEvaxion Biotech AS
      02/01/20249:20AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
      02/01/20249:20AMGlobeNewswire Inc.Evaxion Biotech Announces Pricing of $15 Million Public OfferingNASDAQ:EVAXEvaxion Biotech AS
      01/31/20245:10PMEdgar (US Regulatory)Form F-1/A - Registration statement for certain foreign private issuers: [Amend]NASDAQ:EVAXEvaxion Biotech AS
      01/31/20249:26AMEdgar (US Regulatory)Form F-1/A - Registration statement for certain foreign private issuers: [Amend]NASDAQ:EVAXEvaxion Biotech AS
      01/30/20243:16PMEdgar (US Regulatory)Form F-1/A - Registration statement for certain foreign private issuers: [Amend]NASDAQ:EVAXEvaxion Biotech AS
      01/26/20244:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
       Showing the most relevant articles for your search:NASDAQ:EVAX